(R)-1-(3-氟苯基)乙胺 | 761390-58-3

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (R)-1-(3-氟苯基)乙胺
• 中文别名: (1R)-1-(3-氟苯基)乙胺
• 英文名称: (R)-1-(3-fluorophenyl)ethan-1-amine
• 英文别名: (R)-1-(3-fluorophenyl)ethylamine；(R)-1-(3-fluorophenyl)ethanamine；(1R)-1-(3-fluorophenyl)ethanamine
• CAS: 761390-58-3
• 化学式: C₈H₁₀FN
• mdl: MFCD06761859
• 分子量: 139.173
• InChiKey: ASNVMKIDRJZXQZ-ZCFIWIBFSA-N

物化性质

• 沸点：
  182.6±15.0 °C(Predicted)
• 密度：
  1.063±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2921499090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: (R)-1-(3-Fluorophenyl)ethanamine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: (R)-1-(3-Fluorophenyl)ethanamine
CAS number: 761390-58-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H10FN
Molecular weight: 139.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (R)-1-(3-氟苯基)乙胺 在 甲烷 、 sodium phosphate 、 sodium hydroxide 作用下， 以 乙醇 、 水 、 二甲基亚砜 为溶剂， 反应 103.0h， 生成 3-[4-[(2R)-2-aminopropoxy]phenyl]-N-[(1R)-1-(3-fluorophenyl)ethyl]imidazo[1,2-b]pyridazin-6-amine
  参考文献：
  名称：

  Method for Producing 3, 6-Disubstituted Imidazo[1, 2-b]Pyridazine Derivative

  摘要：

  提供了一种新颖且工业上有用的生产3,6-二取代咪唑[1,2-b]吡嗪衍生物的方法。本发明提供了一种生产3,6-二取代咪唑[1,2-b]吡嗪衍生物的方法，该方法使用6-氟咪唑[1,2-b]吡嗪作为起始物质，同时使用一种利用钯的C-H活化的芳香取代反应。

  公开号：

  US20200062765A1
• 作为产物：
  描述：

  1-(3-氟苯基)-1-乙醇 在 2,2,6,6-四甲基哌啶氧化物 、 Trametes versicolor laccase 、 磷酸吡哆醛 、 transaminase ATA-033 、 异丙胺 作用下， 以 aq. phosphate buffer 、 甲基叔丁基醚 、 二甲基亚砜 为溶剂， 反应 40.0h， 生成 (R)-1-(3-氟苯基)乙胺
  参考文献：
  名称：

  Stereoselective amination of racemic sec-alcohols through sequential application of laccases and transaminases

  摘要：

  已开发出一种一锅法/两步法的化学酶串联方法，通过将来自Trametes versicolor的漆酶/TEMPO催化系统与转氨酶的立体选择性作用相结合，实现了对次级醇的选择性胺化。

  DOI：

  10.1039/c6gc01981a

文献信息

• PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
  申请人：Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

  公开号：US20200247815A1

  公开（公告）日：2020-08-06

  The present invention relates to pyrazolyl-containing tricyclic derivative, a preparation method therefor and the use thereof. In particular, the present invention relates to a compound as shown in the general formula (I), a preparation method therefor and a pharmaceutical composition containing the compound, and the use thereof as a protease such as ERK (MAPK) inhibitor in the treatment of cancers, bone diseases, inflammatory diseases, immunological diseases, nervous system diseases, metabolic diseases, respiratory diseases and heart diseases, wherein the definition of each substituent in the general formula (1) is the same as defined in the description.

  本发明涉及吡唑基含有的三环衍生物，其制备方法及其用途。具体而言，本发明涉及一种如通式(I)所示的化合物，其制备方法及含有该化合物的药物组合物，以及将其用作蛋白酶，如ERK（MAPK）抑制剂，用于治疗癌症、骨疾病、炎症性疾病、免疫疾病、神经系统疾病、代谢性疾病、呼吸系统疾病和心脏疾病，其中通式（1）中每个取代基的定义与描述中定义的相同。
• Transaminases Applied to the Synthesis of High Added-Value Enantiopure Amines
  作者：Caroline E. Paul、María Rodríguez-Mata、Eduardo Busto、Iván Lavandera、Vicente Gotor-Fernández、Vicente Gotor、Susana García-Cerrada、Javier Mendiola、Óscar de Frutos、Iván Collado

  DOI：10.1021/op4003104

  日期：2014.6.20

  stereoselective amination of (hetero)aromatic ketones using transaminases have been studied, such as temperature, pH, substrate concentration, cosolvent, and source and percentage of amino donor, to further optimize the production of enantiopure amines using both (S)- and (R)-selective biocatalysts from commercial suppliers. Interesting enantiopure amino building blocks have been obtained, overcoming some limitations

  研究了使用转氨酶影响（杂）芳族酮的立体选择性胺化的关键参数，例如温度，pH，底物浓度，助溶剂以及氨基供体的来源和百分比，以进一步优化同时使用这两种方法生产对映体纯胺的方法（S） -和（R）选择性生物催化剂来自商业供应商。已经获得了有趣的对映纯氨基结构单元，克服了传统化学合成方法的某些局限性。扩大代表性方法的规模，提供对映体纯形式的卤代和杂芳族胺，分离产率高。
• Synthesis and in vitro EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines
  作者：Svein Jacob Kaspersen、Christopher Sørum、Veronica Willassen、Erik Fuglseth、Eli Kjøbli、Geir Bjørkøy、Eirik Sundby、Bård Helge Hoff

  DOI：10.1016/j.ejmech.2011.10.012

  日期：2011.12

  5-aryl-pyrroles and 4-chloro-6-arylpyrrolopyrimidines. Aromatic substitution with benzylic amines was performed by conventional thermal substitution, and palladium catalysed coupling. The two methods resulted in similar yields, but the palladium coupling had the benefit of lower chemical consumption and reduced reaction times. Eight of the new compounds had IC50 values in the range of 2.8–9.0 nM. Four

  一系列4- Ñ取代-6-芳基- 7 ħ吡咯并[2,3-d]嘧啶-4-胺已被合成，其特征在于和它们的测试在体外EGFR（的ErbB1）酪氨酸激酶抑制活性。该化合物由氰基乙酸乙酯和α-溴乙酰苯经2-氨基-3-乙氧基羰基-5-芳基-吡咯和4-氯-6-芳基吡咯并嘧啶制备。通过常规的热取代和钯催化的偶联进行苄基胺的芳香取代。两种方法的收率相近，但钯偶联具有降低化学药品消耗和缩短反应时间的优点。八个新化合物的IC 50值在2.8–9.0 nM的范围内。这些中的四个具有位于原本可能易于氧化代谢的位点的氟原子。6-芳基的结构变化表明抑制作用仅对该片段中的修饰敏感。然而，效价很大程度上取决于4-氨基芳族部分的结构，除氟以外的任何芳族取代都会降低其体外活性。使用HeLa细胞评估所选化合物的细胞EGFR内在化反应。三种氟化衍生物在抑制EGFR内在化方面具有显著作用。
• Generation of amine dehydrogenases with increased catalytic performance and substrate scope from ε-deaminating L-Lysine dehydrogenase
  作者：Vasilis Tseliou、Tanja Knaus、Marcelo F. Masman、Maria L. Corrado、Francesco G. Mutti

  DOI：10.1038/s41467-019-11509-x

  日期：——

  Amine dehydrogenases (AmDHs) catalyse the conversion of ketones into enantiomerically pure amines at the sole expense of ammonia and hydride source. Guided by structural information from computational models, we create AmDHs that can convert pharmaceutically relevant aromatic ketones with conversions up to quantitative and perfect chemical and optical purities. These AmDHs are created from an unconventional

  胺脱氢酶 (AmDH) 催化酮转化为对映体纯胺，仅消耗氨和氢化物源。在计算模型的结构信息的指导下，我们创建了 AmDH，它可以转化药学相关的芳香酮，并达到定量和完美的化学和光学纯度。这些 AmDH 是由非常规酶支架产生的，该支架显然在其自然反应中不进行任何不对称转化。此外，最佳变体 (LE-AmDH-v1) 显示出独特的底物依赖性对映选择性开关，提供对映体过量高达 >99.9% 的 S-或 R-构型胺产品。这些发现通过计算机研究进行了解释。LE-AmDH-v1 具有高度热稳定性（Tm 为 69 °C），在高达 50 °C 的温度下孵育几天后几乎完全保留其催化活性，并且优先在 50 °C 和 pH 9.0 下运行。这项研究还表明，产物抑制可能是 AmDH 催化还原胺化的关键因素。
• Asymmetric Synthesis of Chiral Primary Amines by Ruthenium-Catalyzed Direct Reductive Amination of Alkyl Aryl Ketones with Ammonium Salts and Molecular H₂
  作者：Xuefeng Tan、Shuang Gao、Weijun Zeng、Shan Xin、Qin Yin、Xumu Zhang

  DOI：10.1021/jacs.7b12898

  日期：2018.2.14

  amination of simple ketones. The strategy makes use of ammonium acetate as the amine source and H2 as the reductant and is a user-friendly and operatively simple access to industrially relevant primary amines. Excellent enantiocontrol (>90% ee for most cases) was achieved with a wide range of alkyl aryl ketones. The practicability of this methodology has been highlighted by scalable synthesis of key intermediates

  钌/C3-TunePhos 催化系统已被确定用于简单酮的高效直接还原胺化。该策略使用乙酸铵作为胺源，H2 作为还原剂，是一种用户友好且操作简单的工业相关伯胺的获取途径。使用范围广泛的烷基芳基酮实现了出色的对映体控制（大多数情况下 >90% ee）。三种药物分子的关键中间体的可扩展合成强调了该方法的实用性。此外，还提出了优化二膦配体 C3-TunePhos 的改进合成路线。